Silence Therapeutics (SLN)

Silence Therapeutics (SLN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• SLN last traded at $19.78, 0.15% on the day.
• Silence Therapeutics: P/E -5.2, revenue $921.49K over the last four quarters.
• Over the past year SLN returned 170.59%; year to date 225.33%.

Updated 2026-11-02 19:07 UTC